The FDA has released data on drug adverse events as part of its OpenFDA initiative to make the information it gathers more readily usable by developers, researchers and the public.
The FDA has released data on drug adverse events as part of its OpenFDA initiative to make the information it gathers more readily usable by developers, researchers and the public.
